Russia targets counterfeit drug distributors
The sale of counterfeit drugs is the target of new legislation proposed by the Russian government, according to news agency Tass.
Senator Anton Belyakov is behind an initiative that seeks to strengthen penalties for those manufacturing, storing, transporting and selling counterfeit drugs and medical devices.
Belyakov has proposed an amendment to section 238 of the Criminal Code, which would allow for jail sentences of between seven and ten years and a fine between 500,000 roubles ($11,000) and one million roubles ($22,000) for anyone responsible for the death of somebody from the consumption of a counterfeit drug.
He was critical of current measures that only prosecute distributors for health and safety violations.
He said: “This means that a counterfeit medicine destined to maintain health, but in fact being immediately dangerous to life, is equated to any other product produced with violation of technological process.
“Counterfeit producers can get away with a fine of 100 thousand roubles ($2,000),” he added.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk